Between the subgroups of malignant endometrium, only endometrial serous carcinoma showed a significant difference from grade 1 endometrioid endometrial carcinoma with its higher immunoreactivity with MMP-9 (p < 0.05) (Figure 1G). The gene discussed is MMP9; the disease is endometrial endometrioid carcinoma.